TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
40,179
|
32,953
|
38,508 |
Financial expenses |
10,440
|
5,301
|
6,133 |
Earnings before taxes |
-15,533
|
-8,570
|
-4,448 |
EBITDA |
2,018
|
1,688
|
8,734 |
Total assets |
176,786
|
168,411
|
161,648 |
Current assets |
39,919
|
58,354
|
54,070 |
Current liabilities |
31,676
|
23,146
|
21,673 |
Equity capital |
52,265
|
66,753
|
49,539 |
- share capital |
7,855
|
7,832
|
5,971 |
Employees (average) |
115
|
105
|
109 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
29.6%
|
39.6%
|
30.6% |
Turnover per employee |
349
|
314
|
353 |
Profit as a percentage of turnover |
-38.7%
|
-26.0%
|
-11.6% |
Return on assets (ROA) |
-2.9%
|
-1.9%
|
1.0% |
Current ratio |
126.0%
|
252.1%
|
249.5% |
Return on equity (ROE) |
-29.7%
|
-12.8%
|
-9.0% |
Change turnover |
7,131
|
-2,436
|
5,421 |
Change turnover % |
22%
|
-7%
|
16% |
Chg. No. of employees |
10
|
-4
|
30 |
Chg. No. of employees % |
10%
|
-4%
|
38% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.